15 insiders reported 163 Form 4 transactions for VERACYTE, INC. (VCYT) over the past 18 months (most recent 2026-06-22). Recent activity: EASTHAM KARIN (Director) Sell 3,200 shares, EASTHAM KARIN (Director) Sell 529 shares, EASTHAM KARIN (Director) Buy 5,272 shares, JONES EVAN/ FA (Director) Buy 5,272 shares, EPSTEIN ROBERT S (Director) Buy 5,272 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | EASTHAM KARIN | Director | Sell | 3,200 | $168,906 |
| 2026-06-22 | EASTHAM KARIN | Director | Sell | 529 | $28,328 |
| 2026-06-15 | EASTHAM KARIN | Director | Buy | 5,272 | $0 |
| 2026-06-15 | JONES EVAN/ FA | Director | Buy | 5,272 | $0 |
| 2026-06-15 | EPSTEIN ROBERT S | Director | Buy | 5,272 | $0 |
| 2026-06-15 | Shafer David Brent | Director | Buy | 5,272 | $0 |
| 2026-06-15 | Holstein Jens | Director | Buy | 5,272 | $0 |
| 2026-06-15 | Bhanji Muna | Director | Buy | 5,272 | $0 |
| 2026-06-15 | Barr Eliav | Director | Buy | 5,272 | $0 |
| 2026-06-15 | Miller Thomas F. | Director | Buy | 5,272 | $0 |
| 2026-06-04 | McGuire Annie | EVP, General Counsel | Sell | 3,292 | $157,358 |
| 2026-06-04 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 1,361 | $65,056 |
| 2026-06-04 | Chambers Rebecca | Chief Financial Officer | Sell | 3,693 | $176,525 |
| 2026-06-04 | Stapley Marc | Chief Executive Officer | Sell | 9,012 | $430,774 |
| 2026-06-04 | Leite John | Global Chief Commercial Off | Sell | 4,059 | $194,020 |
| 2026-06-04 | Chambers Rebecca | Chief Financial Officer | Sell | 1,600 | $78,854 |
| 2026-06-04 | McGuire Annie | EVP, General Counsel | Sell | 1,400 | $69,029 |
| 2026-06-04 | Leite John | Global Chief Commercial Off | Sell | 13,975 | $699,732 |
| 2026-06-04 | Stapley Marc | Chief Executive Officer | Buy | 138,051 | $5.1M |
| 2026-06-04 | Stapley Marc | Chief Executive Officer | Sell | 138,051 | $6.9M |
| 2026-06-04 | Chambers Rebecca | Chief Financial Officer | Sell | 1,961 | $98,229 |
| 2026-06-04 | McGuire Annie | EVP, General Counsel | Sell | 1,776 | $89,007 |
| 2026-06-04 | Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 3,730 | $178,294 |
| 2026-05-27 | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 24,000 | $1.1M |
| 2026-05-27 | Wygant Jonathan | VP, Chief Accounting Officer | Buy | 24,000 | $595,200 |
Source: SEC Form 4 filings · as of 2026-06-22